Benefits of Kinesio Taping and Inhibitory Treatment Techniques in Patients With Fibromyalgia Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 64
- 试验地点
- 2
- 主要终点
- Pain Intensity
研究概览
简要总结
Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS).
Study Design: A single-blind randomized controlled trial was conducted on patients with FMS.
Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed Fibromyalgia Syndrome.
- •Limitation of usual activities due to pain on at least 1 day in the previous 30 days.
- •Agreement to attend evening therapy sessions.
- •Non-practice of regular physical activity.
排除标准
- •A history of surgery.
- •The presence of comorbid conditions (e.g., morbid obesity, inflammatory diseases, irritable bowel syndrome and interstitial cystitis).
- •A history of whiplash injury.
- •Severe physical disability.
- •uncontrolled endocrine disorders (e.g., hyperthyroidism, diabetes); 6) illness (e.g., schizophrenia or substance abuse).
- •The use of medication other than as-needed analgesics (excluding long-term narcotics).
- •Malignancy.
- •Psychiatric disorders.
- •A score of ≥ 9 points in the Beck depression inventory.
结局指标
主要结局
Pain Intensity
时间窗: Changes from Baseline, and 10 weeks
A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.
次要结局
- Pittsburgh Quality of Sleep Questionnaire(Changes from Baseline, and 10 weeks)
- Hospital Anxiety Depression Scale (HADS)(Changes from Baseline, and 10 weeks)
- McGill Pain Questionnaire(Changes from Baseline, and 10 weeks)
- Pain Pressure(Changes from Baseline, and 10 weeks)
- Fibromyalgia Impact Questionnaire (FIQ)(Changes from Baseline, and 10 weeks)
- Beck Inventory for Depression(Changes from Baseline, and 10 weeks)
- State-Trait Anxiety Inventory (STAI)(Changes from Baseline, and 10 weeks)
- Schöber Test(Changes from Baseline, and 10 weeks)
- Widespread pain index(Changes from Baseline, and 10 weeks)
- Quality of Life (SF-36)(Changes from Baseline, and 10 weeks)
- Fatigue Impact Scale(Changes from Baseline, and 10 weeks)
- Symptom severity score(Changes from Baseline, and 10 weeks)
- Measurement Finger-Floor(symptom severity scale)
研究者
Adelaida María Castro-Sánchez
Professor
Universidad de Almeria
